FibroBiologics (FBLG) Institutional Ownership $2.81 -0.27 (-8.77%) (As of 11/14/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for FibroBiologics (NASDAQ:FBLG)Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$8.83MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$176.26K Get FBLG Insider Trade Alerts Want to know when executives and insiders are buying or selling FibroBiologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data FBLG Institutional Buying and Selling by Quarter Ad Crypto 101 MediaMusk Says ‘Dollar Will Be Worth Nothing…’Cash In On the Pro-Crypto America 27 experts reveal their top picks for 2025 Click here to reserve your seat at the Crypto Community Summit. FibroBiologics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/13/2024 The Manufacturers Life Insurance Company 10,264$32K0.0%N/A0.029% 11/12/2024 Charles Schwab Investment Management Inc.69,732$215K0.0%+5.2%0.198% 10/22/2024 Symphony Financial Ltd. Co.23,772$76K0.0%N/A0.067% 8/14/2024Marshall Wace LLP16,702$83K0.0%-67.9%0.047% 8/12/2024Mercer Global Advisors Inc. ADV10,272$51K0.0%N/A0.029% 8/6/2024 Fund Evaluation Group LLC1,055,105$5.27M0.3%N/A3.001% 8/6/2024Cahaba Wealth Management Inc.14,702$73K0.0%N/A0.041% 8/1/2024 Rhumbline Advisers23,057$115K0.0%N/A0.065% 7/31/2024 Cascade Financial Partners LLC315,055$1.57M0.2%N/A0.882% 7/31/2024 Concurrent Investment Advisors LLC35,283$176K0.0%N/A0.099% 7/26/2024 Bank of New York Mellon Corp68,558$342K0.0%N/A0.192% 7/23/2024 RMR Wealth Builders37,360$186K0.0%N/A0.105% 7/18/2024 Saxon Interests Inc.21,214$106K0.1%N/A0.059% 7/17/2024 ERn Financial LLC31,819$159K0.0%N/A0.089% 7/15/2024 Transform Wealth LLC133,890$668K0.1%N/A0.375% (Data available from 1/1/2016 forward) FBLG Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of FBLG shares? During the previous two years, 15 institutional investors and hedge funds held shares of FibroBiologics. The most heavily invested institutionals were Fund Evaluation Group LLC ($5.27M), Cascade Financial Partners LLC ($1.57M), Transform Wealth LLC ($668K), Bank of New York Mellon Corp ($342K), Charles Schwab Investment Management Inc. ($215K), RMR Wealth Builders ($186K), and Concurrent Investment Advisors LLC ($176K).Learn more on FBLG's institutional investors. Which institutional investors have been buying FibroBiologics stock? Of the 14 institutional investors that purchased FibroBiologics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Fund Evaluation Group LLC ($1.06M), Cascade Financial Partners LLC ($315.06K), Transform Wealth LLC ($133.89K), Bank of New York Mellon Corp ($68.56K), RMR Wealth Builders ($37.36K), Concurrent Investment Advisors LLC ($35.28K), and ERn Financial LLC ($31.82K). How much institutional buying is happening at FibroBiologics? Institutional investors have bought a total of 1,783,802 shares in the last 24 months. This purchase volume represents approximately $8.83M in transactions. Which FibroBiologics major shareholders have been selling company stock? The following institutional investors have sold FibroBiologics stock in the last 24 months: Marshall Wace LLP ($35.32K). How much institutional selling is happening at FibroBiologics? Institutional investors have sold a total of 35,323 shares in the last 24 months. This volume of shares sold represents approximately $176.26K in transactions. Related Companies ZVRA Institutional Ownership DNA Institutional Ownership RGNX Institutional Ownership FDMT Institutional Ownership AQST Institutional Ownership CCCC Institutional Ownership CTNM Institutional Ownership RNAC Institutional Ownership GHRS Institutional Ownership ESPR Institutional Ownership This page (NASDAQ:FBLG) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | SponsoredTrump Win = "Bull Trap"?Dan's research shows that the last time the market looked this way, not only did our economy suffer a large su...Stansberry Research | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroBiologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroBiologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
